Treatment of Inoperable and/or Metastatic Biliary Tree Carcinomas With Single-Agent Gemcitabine or in Combination With Levofolinic Acid and Infusional Fluorouracil: Results of a Multicenter Phase II Study-Reference-Cited by-同舟云学术

Treatment of Inoperable and/or Metastatic Biliary Tree Carcinomas With Single-Agent Gemcitabine or in Combination With Levofolinic Acid and Infusional Fluorouracil: Results of a Multicenter Phase II Study

Published:2001-10-15 Issue:20 Volume:19 Page:4089-4091
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gebbia Vittorio,Giuliani Francesco,Maiello Evaristo,Colucci Giuseppe,Verderame Francesco,Borsellino Nicoló,Mauceri Gaetano,Caruso Michele,Tirrito Maria Lina,Valdesi Matteo

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2001.19.20.4089

Reference9 articles.

1. Castro MP: Efficacy of gemcitabine in the treatment of patients with gall bladder carcinoma. Cancer 15: 639,2000-912,

2. Chemotherapy with gemcitabine in patients with advanced gallbladder carcinoma

3. Biliary tract cancer: our experience with gemcitabine treatment

4. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule: Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment outcomes of metastatic biliary tract cancer patients in Japan: the Tokushukai REAl-world data project 04 (TREAD 04);Japanese Journal of Clinical Oncology;2023-10-05

2. Identification of Novel Ribonucleotide Reductase Inhibitors for Therapeutic Application in Bile Tract Cancer: An Advanced Pharmacoinformatics Study;Biomolecules;2022-09-10

3. Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study;Cancers;2022-04-13

4. Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma;Expert Opinion on Investigational Drugs;2021-07-22

5. New Treatment Options for Advanced Biliary Tract Cancer;Current Treatment Options in Oncology;2020-06-29